Wall Street thought Mylan was headed for disaster—now, analysts are raving By: MarketWatch November 06, 2018 at 10:36 AM EST The stock slid nearly 20% since August, but jumped more than 13% after new financial results. Read More >> Related Stocks: Mylan S&P Pharmaceuticals SPDR